Terms: = Lymphoma AND TG, Thyroglobulin
354 results:
1. The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group.
Mallon B; Kaboré R; Couitchere L; Akonde FB; Narison MLR; Budiongo A; Dackono TA; Pondy A; Diedhiou F; Patte C; Steliarova-Foucher E; Clavel J
Pediatr Blood Cancer; 2023 Dec; 70(12):e30664. PubMed ID: 37732944
[TBL] [Abstract] [Full Text] [Related]
2.
Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
[TBL] [Abstract] [Full Text] [Related]
3. G protein-coupled receptor 183 mediates the sensitization of Burkitt lymphoma tumors to CD47 immune checkpoint blockade by anti-CD20/PI3Kδi dual therapy.
Ribeiro ML; Profitós-Pelejà N; Santos JC; Blecua P; Reyes-Garau D; Armengol M; Fernández-Serrano M; Miskin HP; Bosch F; Esteller M; Normant E; Roué G
Front Immunol; 2023; 14():1130052. PubMed ID: 37153563
[TBL] [Abstract] [Full Text] [Related]
4. Cancer in Ecuadorian subjects with Laron syndrome (ELS).
Guevara-Aguirre J; Peña G; Pazmiño G; Acosta W; Saavedra J; Lescano D; Guevara A; Gavilanes AWD
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36971780
[TBL] [Abstract] [Full Text] [Related]
5. Estimating long-term progression-free and overall survival in patients with peripheral T-cell lymphoma: A US population-based oncology simulation model based on 5-year results from the ECHELON-2 trial.
Burke JM; Yu KS; Mordi U; Bloudek B; Liu N; Phillips T
J Manag Care Spec Pharm; 2023 Mar; 29(3):314-323. PubMed ID: 36840956
[No Abstract] [Full Text] [Related]
6. Altered serum lipid levels are associated with prognosis of diffuse large B cell lymphoma and influenced by utility of rituximab.
Wang F; Lu L; Chen H; Yue Y; Sun Y; Yan F; He B; Lin R; Gu W
Ann Hematol; 2023 Feb; 102(2):393-402. PubMed ID: 36670246
[TBL] [Abstract] [Full Text] [Related]
7. Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19
Pennell CA; Campbell H; Storlie MD; Bolivar-Wagers S; Osborn MJ; Refaeli Y; Jensen M; Viaud S; Young TS; Blazar BR
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36521930
[TBL] [Abstract] [Full Text] [Related]
8. CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma.
Kameda T; Shide K; Kamiunten A; Kogure Y; Morishita D; Koya J; Tahira Y; Akizuki K; Yokomizo-Nakano T; Kubota S; Marutsuka K; Sekine M; Hidaka T; Kubuki Y; Kitai Y; Matsuda T; Yoda A; Ohshima T; Sugiyama M; Sashida G; Kataoka K; Ogawa S; Shimoda K
Commun Biol; 2022 Nov; 5(1):1309. PubMed ID: 36446869
[TBL] [Abstract] [Full Text] [Related]
9. Granulomatous myopathy: Sarcoidosis and beyond.
Chompoopong P; Liewluck T
Muscle Nerve; 2023 Mar; 67(3):193-203. PubMed ID: 36352751
[TBL] [Abstract] [Full Text] [Related]
10. Gut-derived Endotoxin-TLR4 Signaling Drives MYC-Ig Translocation to Promote Lymphoproliferation through c-JUN and STAT3 Activation.
Rokan A; Hernandez JC; Nitiyanandan R; Lin ZY; Chen CL; Machida T; Li M; Khanuja J; Chen ML; Tahara SM; Siddiqi I; Machida K
Mol Cancer Res; 2023 Feb; 21(2):155-169. PubMed ID: 36287175
[TBL] [Abstract] [Full Text] [Related]
11. JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL.
Benyoucef A; Haigh K; Cuddihy A; Haigh JJ
Leukemia; 2022 Dec; 36(12):2802-2816. PubMed ID: 36229595
[TBL] [Abstract] [Full Text] [Related]
12. Case Report of
Lee H; Krishnan V; Wirth LJ; Nucera C; Venturina M; Sadow PM; Mita A; Sacks W
Thyroid; 2022 Dec; 32(12):1580-1585. PubMed ID: 36150036
[TBL] [Abstract] [Full Text] [Related]
13. Study on influencing factors of anthracycline-induced subclinical cardiotoxicity in DLBCL patients administered (R)-CHOP.
Dong Q; Ou W; Wang M; Jiang T; Weng Y; Zhou X; Tang X
BMC Cancer; 2022 Sep; 22(1):988. PubMed ID: 36115970
[TBL] [Abstract] [Full Text] [Related]
14. A Retrospective Cohort Study of the Efficacy, Safety, and Clinical Value of 6-TG versus 6-MP Maintenance Therapy in Children with Acute Lymphoblastic Leukemia.
Tu M; Zhang A; Hu L; Wang F
Biomed Res Int; 2022; 2022():7580642. PubMed ID: 36046443
[TBL] [Abstract] [Full Text] [Related]
15. Design and synthesis of versatile GSTP1-specific fluorogenic substrates for the highly sensitive detection of GSTP1 activity in living cells.
Watanabe K; Fujikawa Y; Murakami-Tonami Y; Mori M; Sakata M; Inoue H
Talanta; 2023 Jan; 251():123796. PubMed ID: 35952503
[TBL] [Abstract] [Full Text] [Related]
16. CD137L and CD4 T cells limit BCL6-expressing pre-germinal center B cell expansion and BCL6-driven B cell malignancy.
Ding Z; Quast I; Yan F; Liao Y; Pitt C; O-Donnell K; Robinson MJ; Shi W; Kallies A; Zotos D; Tarlinton DM
Immunol Cell Biol; 2022 Oct; 100(9):705-717. PubMed ID: 35916066
[TBL] [Abstract] [Full Text] [Related]
17. Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations.
Toksvang LN; Lee SHR; Yang JJ; Schmiegelow K
Leukemia; 2022 Jul; 36(7):1749-1758. PubMed ID: 35654820
[TBL] [Abstract] [Full Text] [Related]
18. Nano-curcumin supplementation in critically ill patients with sepsis: a randomized clinical trial investigating the inflammatory biomarkers, oxidative stress indices, endothelial function, clinical outcomes and nutritional status.
Karimi A; Naeini F; Niazkar HR; Tutunchi H; Musazadeh V; Mahmoodpoor A; Asghariazar V; Mobasseri M; Tarighat-Esfanjani A
Food Funct; 2022 Jun; 13(12):6596-6612. PubMed ID: 35621073
[TBL] [Abstract] [Full Text] [Related]
19. Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol.
Toksvang LN; Als-Nielsen B; Bacon C; Bertasiute R; Duarte X; Escherich G; Helgadottir EA; Johannsdottir IR; Jónsson ÓG; Kozlowski P; Langenskjöld C; Lepik K; Niinimäki R; Overgaard UM; Punab M; Räty R; Segers H; van der Sluis I; Smith OP; Strullu M; Vaitkevičienė G; Wik HS; Heyman M; Schmiegelow K
BMC Cancer; 2022 May; 22(1):483. PubMed ID: 35501736
[TBL] [Abstract] [Full Text] [Related]
20. Effects of imatinib on glycemic and lipid profiles: a retrospective cohort study.
Markovits N; Kurnik D; Friedrich C; Gueta I; Halkin H; David S; Lomnicky Y; Topol Y; Tirosh A; Loebstein R
Leuk Lymphoma; 2022 Sep; 63(9):2224-2232. PubMed ID: 35475716
[TBL] [Abstract] [Full Text] [Related]
[Next]